moderna

Moderna and Merck cancer vaccine cuts melanoma recurrence by 44% in late-stage trial

6d ago

Moderna and Merck vaccine cuts melanoma recurrence risk by 44% in phase 3 study

6d ago

Moderna says mRNA flu shot outperformed standard vaccine in older adults

6d ago